Skip to content
OpenCapital
AI Tools
Earnings
Screener
Charts
Watchlist
Pricing
Connect your AI
Get started
Toggle navigation menu
CTO
Citius Oncology, Inc.
CTOR
Net margin
Net margin at other companies
Merck & Co.
MRK
13.6%
-13.7pp
Delcath Systems
DCTH
1.5%
+0.8pp
Iovance Biotherapeutics, Inc.
IOVA
-123.9%
-28.4pp
Immunome
IMNM
-5,593.8%
-11,284pp
Arcus Biosciences
RCUS
-156.4%
-47.5pp
ImmunityBio, Inc.
IBRX
-606.2%
-212pp
Other financials
Income statement
See full
Revenue
$1.7M
—
Gross profit
$1.3M
—
Operating income
-$28.6M
-283%
Net income
-$26.6M
-244%
EPS (diluted)
-$0.27
-145%
Balance sheet
See full
Cash & equivalents
$2.6M
+2,350,466%
Total equity
$35.3M
-1.0%
Total assets
$100.7M
+10.1%
Cash flow
See full
Operating cash flow
-$3.8M
-179%
Valuation
See full
Market cap
$60.45M
-74.7%
Returns & leverage
See full
Return on equity
-119.9%
+46.7pp
Current ratio
0.5×
+0.1×